Patents Assigned to GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
-
Patent number: 11786924Abstract: Aspects of the present invention are directed to a variable dose container. The variable dose container may comprise a container including a top portion, a bottom portion, and a side wall portion, the space between the bottom portion and the side wall portion defining an interior space, wherein the container stores contents within the interior space. The variable dose container may further include an actuator coupled with the top portion of the container that is depressible in a longitudinal direction to drive the contents held in the interior space of the container out of a nozzle protruding horizontally from the actuator. Additionally, the variable dose container may include a collar under the nozzle, a top circumferential edge of the collar containing one or more grooves of varying depth into which the nozzle can be inserted when depressed, thereby adjusting a distance the actuator is moved in the longitudinal direction.Type: GrantFiled: September 20, 2019Date of Patent: October 17, 2023Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLCInventors: Amit Sabherwal, Gregory Ornoski
-
Patent number: 11679139Abstract: A liquid composition comprising witch hazel; glycerin; dehydrated xanthan gum; and water.Type: GrantFiled: March 31, 2021Date of Patent: June 20, 2023Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLCInventors: Shivangi Akash Patel, Renee Nelson
-
Patent number: 11510856Abstract: The invention provides a topical o/w emulsion which moisturizes, and protects, repairs or restores the skin lipid barrier of a mammal. The topical o/w emulsion composition comprises: a) a discontinuous oil phase; b) a continuous aqueous phase comprising water; c) a thickening agent; d) at least one lamellar membrane structure comprising (i) a phospholipid, (ii) a fatty alcohol, and (iii) a fatty acid; e) a pharmaceutically acceptable active agent; and f) optionally a dermatologically acceptable excipient. In one embodiment, the composition, in use, has a water vapor transmission rate of less than or about 75 g·m?2·hr?1 measured in vitro using the modWVTR test methodology.Type: GrantFiled: March 9, 2018Date of Patent: November 29, 2022Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLCInventors: Pallav Arvind Bulsara, Martyn J. Clarke, Dara Lisa Dinner, Alireza Shalviri
-
Patent number: 11433037Abstract: Aspects of the present invention are directed to an oral dosage form comprising a core containing one more active ingredients and a fast-release exterior coating. The fast release exterior coating includes a water soluble polymer; a saccharide or sugar alcohol, or a combination thereof, and a flavoring. The flavoring may be a warming sensate that is released in the oral cavity of the user after inserting the dosage form in his or her mouth.Type: GrantFiled: July 5, 2017Date of Patent: September 6, 2022Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLCInventor: Christopher Joseph Pulford
-
Patent number: 11399575Abstract: Embodiments can provide a wearable device for nicotine cessation behavioral support, comprising a top surface; a first surface; a second surface; an underside surface; a communication device; one or more buttons; an internal storage medium; and a power supply; wherein the one or more buttons are configured to log a NRT use event to the internal storage medium when depressed and subsequently released within a predetermined timeframe; wherein the one or more buttons are configured to log a tobacco use event to the internal storage medium when depressed and released at a time longer than the predetermined timeframe; wherein the one or more buttons, when depressed, are configured to log a craving event to the internal storage medium, wherein an intensity of the craving event is determined by a time duration between depression and release of the one or more buttons.Type: GrantFiled: June 7, 2018Date of Patent: August 2, 2022Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLCInventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
-
Patent number: 10881582Abstract: Aspects of the present invention are directed to an individual dose pack. The individual dose pack may comprise a single serving pod and an overwrap surrounding the entirety of the single serving pod and sealing the single serving pod therein, wherein the overwrap is child-resistant and creates an impermeable barrier being resistant to the passage of liquids and gases. The single serving pod may include a cup, at least one pharmaceutical active ingredient provided in the cup, and a lid affixed to the cup. The overwrap is a multi-layer structure including a first layer being a biaxially-oriented polyethylene terephthalate layer, a second layer being a polyethylene layer, a third layer being an aluminum foil layer, and fourth layer being an ionomer layer.Type: GrantFiled: June 11, 2018Date of Patent: January 5, 2021Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLCInventors: Sriman Banerjee, Kathryn Cramer, Gautam Debnath
-
Patent number: 10350238Abstract: An oral care compositon is described for use in the treatment or alleviation of the symptoms of dry mouth comprising polyvinyl pyrrolidone (PVP) or a derivative thereof, an anionic mucoadhesive polymer and an orally acceptable carrier or excipient.Type: GrantFiled: July 1, 2013Date of Patent: July 16, 2019Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLCInventors: Gertrud Kawa, Shireen Uppal, David Urquhart
-
Patent number: D796335Type: GrantFiled: October 13, 2015Date of Patent: September 5, 2017Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLCInventor: Amit Sabherwal
-
Patent number: D818818Type: GrantFiled: January 16, 2017Date of Patent: May 29, 2018Assignee: GlaxoSmithKline Consumer Healthcare Holdings, US, LLCInventors: Gautam Debnath, Jeffrey Scott Brunner
-
Patent number: D842719Type: GrantFiled: August 2, 2017Date of Patent: March 12, 2019Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLCInventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
-
Patent number: D842720Type: GrantFiled: August 2, 2017Date of Patent: March 12, 2019Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLCInventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
-
Patent number: D854542Type: GrantFiled: August 2, 2017Date of Patent: July 23, 2019Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLCInventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
-
Patent number: D856793Type: GrantFiled: April 27, 2018Date of Patent: August 20, 2019Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLCInventors: Gautam Debnath, Jeffrey Scott Brunner
-
Patent number: D868780Type: GrantFiled: August 2, 2017Date of Patent: December 3, 2019Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLCInventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
-
Patent number: D958645Type: GrantFiled: June 21, 2019Date of Patent: July 26, 2022Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLCInventors: Gautam Debnath, Jeffrey Scott Brunner